GlobeNewswire 02-21 BioCryst to Present at Upcoming Investor Conferences
GlobeNewswire 02-19 BioCryst Launches ORLADEYO® (berotralstat) in Italy
GlobeNewswire 02-12 BioCryst to Report Fourth Quarter 2023 Financial Results on February 26
GlobeNewswire 02-05 BioCryst to Present New ORLADEYO® (berotralstat) Real-world Data at 2024 American Academy of Allergy...
GlobeNewswire 02-02 BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire 01-05 BioCryst Announces Preliminary Full Year 2023 ORLADEYO® (berotralstat) Net Revenue of $325 Million, ...
GlobeNewswire 01-03 BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire 01-03 BioCryst to Present at 42nd Annual J.P. Morgan Healthcare Conference
GlobeNewswire 2023-12-19 BioCryst Announces Publication of Data from Open-label Extension of the APeX-2 Pivotal Trial of ORLA...
GlobeNewswire 2023-12-05 BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire 2023-11-29 BioCryst Announces Approval of ORLADEYO® (berotralstat) by the National Administration of Drugs, Foo...
GlobeNewswire 2023-11-21 BioCryst to Present at Upcoming Investor Conferences
GlobeNewswire 2023-11-21 BioCryst Launches ORLADEYO® (berotralstat) in Spain
GlobeNewswire 2023-11-13 Clearside Biomedical Announces Third Quarter 2023 Financial Results and Provides Corporate Update
GlobeNewswire 2023-11-10 BioCryst Presents New Real-world Data Showing Reduced Attack Rates in Patients with HAE with Normal ...
GlobeNewswire 2023-11-06 BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire 2023-11-03 BioCryst R&D Day Highlights New Diversified Pipeline of First-in-Class/Best-in-Class Therapies with ...
GlobeNewswire 2023-11-03 BioCryst and Clearside Biomedical Enter Partnership to Develop Avoralstat for Diabetic Macular Edema...
GlobeNewswire 2023-11-02 BioCryst Reports Third Quarter 2023 Financial Results and Provides Business Update
GlobeNewswire 2023-10-27 BioCryst to Present New ORLADEYO® (berotralstat) Data at Annual Scientific Meeting of American Colle...
GlobeNewswire 2023-10-26 BioCryst Begins Enrollment in Proof-of-Concept Trial to Confirm Safe, Effective, Once-daily Dose of ...
GlobeNewswire 2023-10-20 BioCryst to Host R&D Day on November 3
GlobeNewswire 2023-10-19 BioCryst to Report Third Quarter 2023 Financial Results on November 2
GlobeNewswire 2023-10-04 BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire 2023-09-20 Parexel’s Amy McKee, M.D. Named to 2023 PharmaVoice 100